Tag Archives: clinical trials

Replicor publishes its REP 301-LTF study achieving durable functional cure of HDV and HBV, inactivation of cccDNA and elimination of integrated HBV DNA

Below, we are re-publishing with permission the press-release issued by Replicor Inc. on November 16, 2020 MONTREAL, November 16th, 2020 – Replicor Inc., a privately held biopharmaceutical company targeting functional cure for patients with chronic hepatitis B and D infection, … Continue reading

Posted in Biotech, Central and Eastern Europe, ClinAccel.Net, Clinical Accelerator | Tagged , , , , | Leave a comment

Sequana Medical announces strong interim results from RED DESERT alfapump® DSR study and provides business update

Below, we are re-publishing with permission the press-release issued by Sequana Medical on October 22, 2020 RED DESERT: Results from first five patients indicate repeated dose alfapump DSR therapy to be safe and effective Interim data support DSR hypothesis: kidneys … Continue reading

Posted in Central and Eastern Europe, Clinical Accelerator, Medical Devices | Tagged | Leave a comment

Galmed Collaboration Announcement

Clinical Accelerator are very pleased to announce collaboration with Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD), on conducting a phase IIB clinical trial for the treatment of patients with overweight or obesity and who are pre diabetic or type II diabetic with … Continue reading

Posted in Clinical Accelerator | Tagged | Leave a comment

The importance of study feasibility

With the finances involved and continuing risk of failure, the importance of careful feasibility assessment and judgment is absolute. To what extent weak – or no – feasibility assessment contributes to clinical trial failures is a challenging question. Feasibility study The … Continue reading

Posted in Feasibility Assessment | Tagged , | Leave a comment